IBDEI03Y ; ; 01-MAY-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 01, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9459,1,4,0)
 ;;=4^N32.81
 ;;^UTILITY(U,$J,358.3,9459,2)
 ;;=^5015652
 ;;^UTILITY(U,$J,358.3,9460,0)
 ;;=Q61.2^^48^485^86
 ;;^UTILITY(U,$J,358.3,9460,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9460,1,3,0)
 ;;=3^Polycystic Kidney,Adult Type
 ;;^UTILITY(U,$J,358.3,9460,1,4,0)
 ;;=4^Q61.2
 ;;^UTILITY(U,$J,358.3,9460,2)
 ;;=^5018796
 ;;^UTILITY(U,$J,358.3,9461,0)
 ;;=N41.1^^48^485^90
 ;;^UTILITY(U,$J,358.3,9461,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9461,1,3,0)
 ;;=3^Prostatitis,Chronic
 ;;^UTILITY(U,$J,358.3,9461,1,4,0)
 ;;=4^N41.1
 ;;^UTILITY(U,$J,358.3,9461,2)
 ;;=^186931
 ;;^UTILITY(U,$J,358.3,9462,0)
 ;;=N11.9^^48^485^98
 ;;^UTILITY(U,$J,358.3,9462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9462,1,3,0)
 ;;=3^Pyelonephritis,Chronic,Unspec
 ;;^UTILITY(U,$J,358.3,9462,1,4,0)
 ;;=4^N11.9
 ;;^UTILITY(U,$J,358.3,9462,2)
 ;;=^5015574
 ;;^UTILITY(U,$J,358.3,9463,0)
 ;;=N20.9^^48^485^116
 ;;^UTILITY(U,$J,358.3,9463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9463,1,3,0)
 ;;=3^Urinary Calculus,Unspec
 ;;^UTILITY(U,$J,358.3,9463,1,4,0)
 ;;=4^N20.9
 ;;^UTILITY(U,$J,358.3,9463,2)
 ;;=^5015610
 ;;^UTILITY(U,$J,358.3,9464,0)
 ;;=R97.20^^48^485^29
 ;;^UTILITY(U,$J,358.3,9464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9464,1,3,0)
 ;;=3^Elevated PSA
 ;;^UTILITY(U,$J,358.3,9464,1,4,0)
 ;;=4^R97.20
 ;;^UTILITY(U,$J,358.3,9464,2)
 ;;=^334262
 ;;^UTILITY(U,$J,358.3,9465,0)
 ;;=N52.36^^48^485^34
 ;;^UTILITY(U,$J,358.3,9465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9465,1,3,0)
 ;;=3^Erectile Dysfunction After Interstitial Seed Therapy
 ;;^UTILITY(U,$J,358.3,9465,1,4,0)
 ;;=4^N52.36
 ;;^UTILITY(U,$J,358.3,9465,2)
 ;;=^5138933
 ;;^UTILITY(U,$J,358.3,9466,0)
 ;;=N52.37^^48^485^35
 ;;^UTILITY(U,$J,358.3,9466,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9466,1,3,0)
 ;;=3^Erectile Dysfunction After Prostate Ablative Therapy
 ;;^UTILITY(U,$J,358.3,9466,1,4,0)
 ;;=4^N52.37
 ;;^UTILITY(U,$J,358.3,9466,2)
 ;;=^5138934
 ;;^UTILITY(U,$J,358.3,9467,0)
 ;;=N52.35^^48^485^36
 ;;^UTILITY(U,$J,358.3,9467,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9467,1,3,0)
 ;;=3^Erectile Dysfunction After Radiation Therapy
 ;;^UTILITY(U,$J,358.3,9467,1,4,0)
 ;;=4^N52.35
 ;;^UTILITY(U,$J,358.3,9467,2)
 ;;=^5138932
 ;;^UTILITY(U,$J,358.3,9468,0)
 ;;=R31.21^^48^485^56
 ;;^UTILITY(U,$J,358.3,9468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9468,1,3,0)
 ;;=3^Hematuria,Microscopic,Asymptomatic
 ;;^UTILITY(U,$J,358.3,9468,1,4,0)
 ;;=4^R31.21
 ;;^UTILITY(U,$J,358.3,9468,2)
 ;;=^5139198
 ;;^UTILITY(U,$J,358.3,9469,0)
 ;;=R31.29^^48^485^57
 ;;^UTILITY(U,$J,358.3,9469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9469,1,3,0)
 ;;=3^Hematuria,Microscopic,Other
 ;;^UTILITY(U,$J,358.3,9469,1,4,0)
 ;;=4^R31.29
 ;;^UTILITY(U,$J,358.3,9469,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,9470,0)
 ;;=R39.198^^48^485^70
 ;;^UTILITY(U,$J,358.3,9470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9470,1,3,0)
 ;;=3^Micturition,Oth Difficulties
 ;;^UTILITY(U,$J,358.3,9470,1,4,0)
 ;;=4^R39.198
 ;;^UTILITY(U,$J,358.3,9470,2)
 ;;=^5019347
 ;;^UTILITY(U,$J,358.3,9471,0)
 ;;=R39.191^^48^485^72
 ;;^UTILITY(U,$J,358.3,9471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9471,1,3,0)
 ;;=3^Need to Immediately Re-Void
 ;;^UTILITY(U,$J,358.3,9471,1,4,0)
 ;;=4^R39.191
 ;;^UTILITY(U,$J,358.3,9471,2)
 ;;=^5139199
 ;;^UTILITY(U,$J,358.3,9472,0)
 ;;=R39.192^^48^485^71
 ;;^UTILITY(U,$J,358.3,9472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9472,1,3,0)
 ;;=3^Micturition,Position Dependent
 ;;^UTILITY(U,$J,358.3,9472,1,4,0)
 ;;=4^R39.192
 ;;^UTILITY(U,$J,358.3,9472,2)
 ;;=^5139200
 ;;^UTILITY(U,$J,358.3,9473,0)
 ;;=R97.21^^48^485^101
 ;;^UTILITY(U,$J,358.3,9473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9473,1,3,0)
 ;;=3^Rising PSA After Tx for Prostate CA
 ;;^UTILITY(U,$J,358.3,9473,1,4,0)
 ;;=4^R97.21
 ;;^UTILITY(U,$J,358.3,9473,2)
 ;;=^5139228
 ;;^UTILITY(U,$J,358.3,9474,0)
 ;;=N50.82^^48^485^102
 ;;^UTILITY(U,$J,358.3,9474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9474,1,3,0)
 ;;=3^Scrotal Pain
 ;;^UTILITY(U,$J,358.3,9474,1,4,0)
 ;;=4^N50.82
 ;;^UTILITY(U,$J,358.3,9474,2)
 ;;=^5138930
 ;;^UTILITY(U,$J,358.3,9475,0)
 ;;=N50.812^^48^485^106
 ;;^UTILITY(U,$J,358.3,9475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9475,1,3,0)
 ;;=3^Testicular Pain,Left Side
 ;;^UTILITY(U,$J,358.3,9475,1,4,0)
 ;;=4^N50.812
 ;;^UTILITY(U,$J,358.3,9475,2)
 ;;=^5138928
 ;;^UTILITY(U,$J,358.3,9476,0)
 ;;=N50.811^^48^485^107
 ;;^UTILITY(U,$J,358.3,9476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9476,1,3,0)
 ;;=3^Testicular Pain,Right Side
 ;;^UTILITY(U,$J,358.3,9476,1,4,0)
 ;;=4^N50.811
 ;;^UTILITY(U,$J,358.3,9476,2)
 ;;=^5138927
 ;;^UTILITY(U,$J,358.3,9477,0)
 ;;=N35.919^^48^485^112
 ;;^UTILITY(U,$J,358.3,9477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9477,1,3,0)
 ;;=3^Urethral Stricture,NOS,Male
 ;;^UTILITY(U,$J,358.3,9477,1,4,0)
 ;;=4^N35.919
 ;;^UTILITY(U,$J,358.3,9477,2)
 ;;=^5157412
 ;;^UTILITY(U,$J,358.3,9478,0)
 ;;=N35.92^^48^485^111
 ;;^UTILITY(U,$J,358.3,9478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9478,1,3,0)
 ;;=3^Urethral Stricture,NOS,Female
 ;;^UTILITY(U,$J,358.3,9478,1,4,0)
 ;;=4^N35.92
 ;;^UTILITY(U,$J,358.3,9478,2)
 ;;=^5157413
 ;;^UTILITY(U,$J,358.3,9479,0)
 ;;=R82.81^^48^485^99
 ;;^UTILITY(U,$J,358.3,9479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9479,1,3,0)
 ;;=3^Pyuria
 ;;^UTILITY(U,$J,358.3,9479,1,4,0)
 ;;=4^R82.81
 ;;^UTILITY(U,$J,358.3,9479,2)
 ;;=^101879
 ;;^UTILITY(U,$J,358.3,9480,0)
 ;;=R51.^^48^486^2
 ;;^UTILITY(U,$J,358.3,9480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9480,1,3,0)
 ;;=3^Headache
 ;;^UTILITY(U,$J,358.3,9480,1,4,0)
 ;;=4^R51.
 ;;^UTILITY(U,$J,358.3,9480,2)
 ;;=^5019513
 ;;^UTILITY(U,$J,358.3,9481,0)
 ;;=G44.1^^48^486^9
 ;;^UTILITY(U,$J,358.3,9481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9481,1,3,0)
 ;;=3^Vascular Headache NEC
 ;;^UTILITY(U,$J,358.3,9481,1,4,0)
 ;;=4^G44.1
 ;;^UTILITY(U,$J,358.3,9481,2)
 ;;=^5003934
 ;;^UTILITY(U,$J,358.3,9482,0)
 ;;=G43.909^^48^486^5
 ;;^UTILITY(U,$J,358.3,9482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9482,1,3,0)
 ;;=3^Migraine,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,9482,1,4,0)
 ;;=4^G43.909
 ;;^UTILITY(U,$J,358.3,9482,2)
 ;;=^5003909
 ;;^UTILITY(U,$J,358.3,9483,0)
 ;;=G44.009^^48^486^1
 ;;^UTILITY(U,$J,358.3,9483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9483,1,3,0)
 ;;=3^Cluster Headache,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,9483,1,4,0)
 ;;=4^G44.009
 ;;^UTILITY(U,$J,358.3,9483,2)
 ;;=^5003921
 ;;^UTILITY(U,$J,358.3,9484,0)
 ;;=G44.40^^48^486^4
 ;;^UTILITY(U,$J,358.3,9484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9484,1,3,0)
 ;;=3^Medication Overuse Headache,Not Intractable
 ;;^UTILITY(U,$J,358.3,9484,1,4,0)
 ;;=4^G44.40
 ;;^UTILITY(U,$J,358.3,9484,2)
 ;;=^5003947
 ;;^UTILITY(U,$J,358.3,9485,0)
 ;;=G44.89^^48^486^3
 ;;^UTILITY(U,$J,358.3,9485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9485,1,3,0)
 ;;=3^Headache Syndrome NEC
 ;;^UTILITY(U,$J,358.3,9485,1,4,0)
 ;;=4^G44.89
 ;;^UTILITY(U,$J,358.3,9485,2)
 ;;=^5003954
 ;;^UTILITY(U,$J,358.3,9486,0)
 ;;=G44.84^^48^486^7
 ;;^UTILITY(U,$J,358.3,9486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9486,1,3,0)
 ;;=3^Primary Exertional Headache
 ;;^UTILITY(U,$J,358.3,9486,1,4,0)
 ;;=4^G44.84
 ;;^UTILITY(U,$J,358.3,9486,2)
 ;;=^336563
 ;;^UTILITY(U,$J,358.3,9487,0)
 ;;=G44.301^^48^486^6
 ;;^UTILITY(U,$J,358.3,9487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9487,1,3,0)
 ;;=3^Post-Traumatic Headache,Unspec,Intractable
 ;;^UTILITY(U,$J,358.3,9487,1,4,0)
 ;;=4^G44.301
 ;;^UTILITY(U,$J,358.3,9487,2)
 ;;=^5003941
 ;;^UTILITY(U,$J,358.3,9488,0)
 ;;=G44.209^^48^486^8
 ;;^UTILITY(U,$J,358.3,9488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9488,1,3,0)
 ;;=3^Tension-Type Headache,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,9488,1,4,0)
 ;;=4^G44.209
 ;;^UTILITY(U,$J,358.3,9488,2)
 ;;=^5003936
 ;;^UTILITY(U,$J,358.3,9489,0)
 ;;=I30.0^^48^487^5
 ;;^UTILITY(U,$J,358.3,9489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9489,1,3,0)
 ;;=3^Idiopathic Pericarditis,Acute Nonspec
 ;;^UTILITY(U,$J,358.3,9489,1,4,0)
 ;;=4^I30.0
 ;;^UTILITY(U,$J,358.3,9489,2)
 ;;=^5007157
 ;;^UTILITY(U,$J,358.3,9490,0)
 ;;=I34.8^^48^487^6
 ;;^UTILITY(U,$J,358.3,9490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9490,1,3,0)
 ;;=3^Mitral Valve Disorders,Nonrheumatic Other
 ;;^UTILITY(U,$J,358.3,9490,1,4,0)
 ;;=4^I34.8
 ;;^UTILITY(U,$J,358.3,9490,2)
 ;;=^5007172
 ;;^UTILITY(U,$J,358.3,9491,0)
 ;;=I34.0^^48^487^13
 ;;^UTILITY(U,$J,358.3,9491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9491,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,9491,1,4,0)
 ;;=4^I34.0
 ;;^UTILITY(U,$J,358.3,9491,2)
 ;;=^5007169
 ;;^UTILITY(U,$J,358.3,9492,0)
 ;;=I34.9^^48^487^12
 ;;^UTILITY(U,$J,358.3,9492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9492,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,9492,1,4,0)
 ;;=4^I34.9
 ;;^UTILITY(U,$J,358.3,9492,2)
 ;;=^5007173
 ;;^UTILITY(U,$J,358.3,9493,0)
 ;;=I34.2^^48^487^7
 ;;^UTILITY(U,$J,358.3,9493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9493,1,3,0)
 ;;=3^Nonrhematic Mitral Valve Stenosis
 ;;^UTILITY(U,$J,358.3,9493,1,4,0)
 ;;=4^I34.2
 ;;^UTILITY(U,$J,358.3,9493,2)
 ;;=^5007171
 ;;^UTILITY(U,$J,358.3,9494,0)
 ;;=I35.0^^48^487^10
 ;;^UTILITY(U,$J,358.3,9494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9494,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis
 ;;^UTILITY(U,$J,358.3,9494,1,4,0)
 ;;=4^I35.0
 ;;^UTILITY(U,$J,358.3,9494,2)
 ;;=^5007174
 ;;^UTILITY(U,$J,358.3,9495,0)
 ;;=I35.1^^48^487^9
 ;;^UTILITY(U,$J,358.3,9495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9495,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,9495,1,4,0)
 ;;=4^I35.1
 ;;^UTILITY(U,$J,358.3,9495,2)
 ;;=^5007175
 ;;^UTILITY(U,$J,358.3,9496,0)
 ;;=I35.2^^48^487^11
 ;;^UTILITY(U,$J,358.3,9496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9496,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
 ;;^UTILITY(U,$J,358.3,9496,1,4,0)
 ;;=4^I35.2
 ;;^UTILITY(U,$J,358.3,9496,2)
 ;;=^5007176
 ;;^UTILITY(U,$J,358.3,9497,0)
 ;;=I35.9^^48^487^8
 ;;^UTILITY(U,$J,358.3,9497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9497,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,9497,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,9497,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,9498,0)
 ;;=I38.^^48^487^4
 ;;^UTILITY(U,$J,358.3,9498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9498,1,3,0)
 ;;=3^Endocarditis,Valve Unspec
 ;;^UTILITY(U,$J,358.3,9498,1,4,0)
 ;;=4^I38.
 ;;^UTILITY(U,$J,358.3,9498,2)
 ;;=^40327
 ;;^UTILITY(U,$J,358.3,9499,0)
 ;;=I05.0^^48^487^18
 ;;^UTILITY(U,$J,358.3,9499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9499,1,3,0)
 ;;=3^Rheumatic Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,9499,1,4,0)
 ;;=4^I05.0
 ;;^UTILITY(U,$J,358.3,9499,2)
 ;;=^5007041
 ;;^UTILITY(U,$J,358.3,9500,0)
 ;;=I05.8^^48^487^19
 ;;^UTILITY(U,$J,358.3,9500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9500,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease NEC
 ;;^UTILITY(U,$J,358.3,9500,1,4,0)
 ;;=4^I05.8
 ;;^UTILITY(U,$J,358.3,9500,2)
 ;;=^5007043
 ;;^UTILITY(U,$J,358.3,9501,0)
 ;;=I05.9^^48^487^20
 ;;^UTILITY(U,$J,358.3,9501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9501,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,9501,1,4,0)
 ;;=4^I05.9
 ;;^UTILITY(U,$J,358.3,9501,2)
 ;;=^5007044
 ;;^UTILITY(U,$J,358.3,9502,0)
 ;;=I07.1^^48^487^21
 ;;^UTILITY(U,$J,358.3,9502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9502,1,3,0)
 ;;=3^Rheumatic Tricuspid Insufficiency
 ;;^UTILITY(U,$J,358.3,9502,1,4,0)
 ;;=4^I07.1
 ;;^UTILITY(U,$J,358.3,9502,2)
 ;;=^5007048
 ;;^UTILITY(U,$J,358.3,9503,0)
 ;;=I07.9^^48^487^22
 ;;^UTILITY(U,$J,358.3,9503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9503,1,3,0)
 ;;=3^Rheumatic Tricuspid Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,9503,1,4,0)
 ;;=4^I07.9
 ;;^UTILITY(U,$J,358.3,9503,2)
 ;;=^5007051
 ;;^UTILITY(U,$J,358.3,9504,0)
 ;;=I08.0^^48^487^16
 ;;^UTILITY(U,$J,358.3,9504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9504,1,3,0)
 ;;=3^Rheumatic Disorders of Mitral & Aortic Valves
 ;;^UTILITY(U,$J,358.3,9504,1,4,0)
 ;;=4^I08.0
 ;;^UTILITY(U,$J,358.3,9504,2)
 ;;=^5007052
 ;;^UTILITY(U,$J,358.3,9505,0)
 ;;=I09.89^^48^487^17
 ;;^UTILITY(U,$J,358.3,9505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9505,1,3,0)
 ;;=3^Rheumatic Heart Diseases NEC
 ;;^UTILITY(U,$J,358.3,9505,1,4,0)
 ;;=4^I09.89
 ;;^UTILITY(U,$J,358.3,9505,2)
 ;;=^5007060
 ;;^UTILITY(U,$J,358.3,9506,0)
 ;;=I47.1^^48^487^24
 ;;^UTILITY(U,$J,358.3,9506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9506,1,3,0)
 ;;=3^Supraventricular Tachycardia
 ;;^UTILITY(U,$J,358.3,9506,1,4,0)
 ;;=4^I47.1
 ;;^UTILITY(U,$J,358.3,9506,2)
 ;;=^5007223
 ;;^UTILITY(U,$J,358.3,9507,0)
 ;;=I48.0^^48^487^15
 ;;^UTILITY(U,$J,358.3,9507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9507,1,3,0)
 ;;=3^Paroxysmal Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,9507,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,9507,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,9508,0)
 ;;=I49.5^^48^487^23
 ;;^UTILITY(U,$J,358.3,9508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9508,1,3,0)
 ;;=3^Sick Sinus Syndrome
 ;;^UTILITY(U,$J,358.3,9508,1,4,0)
 ;;=4^I49.5
 ;;^UTILITY(U,$J,358.3,9508,2)
 ;;=^110404
 ;;^UTILITY(U,$J,358.3,9509,0)
 ;;=I49.8^^48^487^3
 ;;^UTILITY(U,$J,358.3,9509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9509,1,3,0)
 ;;=3^Cardiac Arrhythmias
 ;;^UTILITY(U,$J,358.3,9509,1,4,0)
 ;;=4^I49.8
 ;;^UTILITY(U,$J,358.3,9509,2)
 ;;=^5007236
 ;;^UTILITY(U,$J,358.3,9510,0)
 ;;=I49.9^^48^487^2
 ;;^UTILITY(U,$J,358.3,9510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9510,1,3,0)
 ;;=3^Cardiac Arrhythmia,Unspec
 ;;^UTILITY(U,$J,358.3,9510,1,4,0)
 ;;=4^I49.9
 ;;^UTILITY(U,$J,358.3,9510,2)
 ;;=^5007237
 ;;^UTILITY(U,$J,358.3,9511,0)
 ;;=R00.1^^48^487^1
 ;;^UTILITY(U,$J,358.3,9511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9511,1,3,0)
 ;;=3^Bradycardia,Unspec
 ;;^UTILITY(U,$J,358.3,9511,1,4,0)
 ;;=4^R00.1
 ;;^UTILITY(U,$J,358.3,9511,2)
 ;;=^5019164
 ;;^UTILITY(U,$J,358.3,9512,0)
 ;;=I34.1^^48^487^14
 ;;^UTILITY(U,$J,358.3,9512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9512,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Prolapse
 ;;^UTILITY(U,$J,358.3,9512,1,4,0)
 ;;=4^I34.1
 ;;^UTILITY(U,$J,358.3,9512,2)
 ;;=^5007170
 ;;^UTILITY(U,$J,358.3,9513,0)
 ;;=D68.4^^48^488^1
 ;;^UTILITY(U,$J,358.3,9513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9513,1,3,0)
 ;;=3^Acquired Coagulation Factor Deficiency
 ;;^UTILITY(U,$J,358.3,9513,1,4,0)
 ;;=4^D68.4
 ;;^UTILITY(U,$J,358.3,9513,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,9514,0)
 ;;=D59.9^^48^488^2
 ;;^UTILITY(U,$J,358.3,9514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9514,1,3,0)
 ;;=3^Acquired Hemolytic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,9514,1,4,0)
 ;;=4^D59.9
 ;;^UTILITY(U,$J,358.3,9514,2)
 ;;=^5002330
 ;;^UTILITY(U,$J,358.3,9515,0)
 ;;=C91.00^^48^488^5
 ;;^UTILITY(U,$J,358.3,9515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9515,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,9515,1,4,0)
 ;;=4^C91.00
 ;;^UTILITY(U,$J,358.3,9515,2)
 ;;=^5001762
 ;;^UTILITY(U,$J,358.3,9516,0)
 ;;=C91.01^^48^488^4
 ;;^UTILITY(U,$J,358.3,9516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9516,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,9516,1,4,0)
 ;;=4^C91.01
 ;;^UTILITY(U,$J,358.3,9516,2)
 ;;=^5001763
 ;;^UTILITY(U,$J,358.3,9517,0)
 ;;=C92.01^^48^488^7
 ;;^UTILITY(U,$J,358.3,9517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9517,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,9517,1,4,0)
 ;;=4^C92.01
 ;;^UTILITY(U,$J,358.3,9517,2)
 ;;=^5001790
 ;;^UTILITY(U,$J,358.3,9518,0)
 ;;=C92.00^^48^488^8
 ;;^UTILITY(U,$J,358.3,9518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9518,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,9518,1,4,0)
 ;;=4^C92.00
 ;;^UTILITY(U,$J,358.3,9518,2)
 ;;=^5001789
 ;;^UTILITY(U,$J,358.3,9519,0)
 ;;=C92.61^^48^488^9
 ;;^UTILITY(U,$J,358.3,9519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9519,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,In Remission
 ;;^UTILITY(U,$J,358.3,9519,1,4,0)
 ;;=4^C92.61
 ;;^UTILITY(U,$J,358.3,9519,2)
 ;;=^5001808
 ;;^UTILITY(U,$J,358.3,9520,0)
 ;;=C92.60^^48^488^10
 ;;^UTILITY(U,$J,358.3,9520,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9520,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,Not in Remission
 ;;^UTILITY(U,$J,358.3,9520,1,4,0)
 ;;=4^C92.60
 ;;^UTILITY(U,$J,358.3,9520,2)
 ;;=^5001807
 ;;^UTILITY(U,$J,358.3,9521,0)
 ;;=C92.A1^^48^488^11
 ;;^UTILITY(U,$J,358.3,9521,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9521,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,In Remission
 ;;^UTILITY(U,$J,358.3,9521,1,4,0)
 ;;=4^C92.A1
 ;;^UTILITY(U,$J,358.3,9521,2)
 ;;=^5001814
 ;;^UTILITY(U,$J,358.3,9522,0)
 ;;=C92.A0^^48^488^12
 ;;^UTILITY(U,$J,358.3,9522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9522,1,3,0)
 ;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,Not in Remission
 ;;^UTILITY(U,$J,358.3,9522,1,4,0)
 ;;=4^C92.A0
 ;;^UTILITY(U,$J,358.3,9522,2)
 ;;=^5001813
 ;;^UTILITY(U,$J,358.3,9523,0)
 ;;=C92.51^^48^488^13
 ;;^UTILITY(U,$J,358.3,9523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9523,1,3,0)
 ;;=3^Acute Myelomonocytic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,9523,1,4,0)
 ;;=4^C92.51
 ;;^UTILITY(U,$J,358.3,9523,2)
 ;;=^5001805
 ;;^UTILITY(U,$J,358.3,9524,0)
 ;;=C92.50^^48^488^14
 ;;^UTILITY(U,$J,358.3,9524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9524,1,3,0)
 ;;=3^Acute Myelomonocytic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,9524,1,4,0)
 ;;=4^C92.50
 ;;^UTILITY(U,$J,358.3,9524,2)
 ;;=^5001804
 ;;^UTILITY(U,$J,358.3,9525,0)
 ;;=C94.40^^48^488^17
 ;;^UTILITY(U,$J,358.3,9525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9525,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,Not in Remission
 ;;^UTILITY(U,$J,358.3,9525,1,4,0)
 ;;=4^C94.40
 ;;^UTILITY(U,$J,358.3,9525,2)
 ;;=^5001843
 ;;^UTILITY(U,$J,358.3,9526,0)
 ;;=C94.42^^48^488^15
 ;;^UTILITY(U,$J,358.3,9526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9526,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Relapse
 ;;^UTILITY(U,$J,358.3,9526,1,4,0)
 ;;=4^C94.42
 ;;^UTILITY(U,$J,358.3,9526,2)
 ;;=^5001845
 ;;^UTILITY(U,$J,358.3,9527,0)
 ;;=C94.41^^48^488^16
 ;;^UTILITY(U,$J,358.3,9527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9527,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Remission
 ;;^UTILITY(U,$J,358.3,9527,1,4,0)
 ;;=4^C94.41
 ;;^UTILITY(U,$J,358.3,9527,2)
 ;;=^5001844
 ;;^UTILITY(U,$J,358.3,9528,0)
 ;;=D62.^^48^488^18
 ;;^UTILITY(U,$J,358.3,9528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9528,1,3,0)
 ;;=3^Acute Posthemorrhagic Anemia
 ;;^UTILITY(U,$J,358.3,9528,1,4,0)
 ;;=4^D62.
 ;;^UTILITY(U,$J,358.3,9528,2)
 ;;=^267986
